These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35417613)

  • 1. Association between changes in bodyweight and cardiovascular disease risk factors among obese Japanese patients with type 2 diabetes.
    Yoshimura R; Nakagami T; Hasegawa Y; Oya J; Babazono T
    J Diabetes Investig; 2022 Sep; 13(9):1560-1566. PubMed ID: 35417613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-specific associations of fat mass and muscle mass with cardiovascular disease risk factors in adults with type 2 diabetes living with overweight and obesity: secondary analysis of the Look AHEAD trial.
    Terada T; Reed JL; Vidal-Almela S; Mistura M; Kamiya K; Way KL
    Cardiovasc Diabetol; 2022 Mar; 21(1):40. PubMed ID: 35292039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women.
    Chang CJ; Wu CH; Yao WJ; Yang YC; Wu JS; Lu FH
    Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1699-704. PubMed ID: 11126227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
    Bertoni AG; Clark JM; Feeney P; Yanovski SZ; Bantle J; Montgomery B; Safford MM; Herman WH; Haffner S;
    J Diabetes Complications; 2008; 22(1):1-9. PubMed ID: 18191071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in body mass index, glycosylated hemoglobin A1C, blood pressure, and LDL-cholesterol among type 2 diabetes patients in Malaysia: A population-based longitudinal study.
    Wan KS; Moy FM; Mustapha FI; Ismail M; Hairi NN
    J Diabetes; 2021 Nov; 13(11):915-929. PubMed ID: 34142456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal.
    Zhang DA; Katznelson L; Li M
    J Diabetes Sci Technol; 2012 Mar; 6(2):289-93. PubMed ID: 22538137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved cardiometabolic risk factors in Japanese patients with type 2 diabetes treated with ipragliflozin: a pooled analysis of six randomized, placebo-controlled trials.
    Kashiwagi A; Sakatani T; Nakamura I; Akiyama N; Kazuta K; Ueyama E; Takahashi H; Kosakai Y
    Endocr J; 2018 Jul; 65(7):693-705. PubMed ID: 29848902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes.
    Mansour A; Mohajeri-Tehrani MR; Qorbani M; Heshmat R; Larijani B; Hosseini S
    Nutrition; 2015 Jan; 31(1):119-26. PubMed ID: 25466655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus.
    Salinero-Fort MA; Carrillo-de Santa Pau E; Arrieta-Blanco FJ; Abanades-Herranz JC; Martín-Madrazo C; Rodés-Soldevila B; de Burgos-Lunar C
    BMC Public Health; 2011 Apr; 11():267. PubMed ID: 21524316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of telephone call intervention on cardiovascular risk factors in T2DM: A meta-analysis.
    Wei J; Zheng H; Wang L; Wang Q; Wei F; Bai L
    J Telemed Telecare; 2019 Feb; 25(2):93-105. PubMed ID: 29228855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials.
    Kashiwagi A; Yoshida S; Nakamura I; Kazuta K; Ueyama E; Takahashi H; Satomi H; Kosakai Y; Kawamuki K
    J Diabetes Investig; 2016 Jul; 7(4):544-54. PubMed ID: 27181576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
    de Ritter R; Sep SJS; van der Kallen CJH; Schram MT; Koster A; Kroon AA; van Greevenbroek MMJ; Eussen SJPM; Dagnelie PC; de Jong M; Vos RC; Woodward M; Bots ML; Peters SAE; Stehouwer CDA
    BMJ Open Diabetes Res Care; 2019; 7(1):e000787. PubMed ID: 31798903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classical cardiovascular risk factors in Trinidadian patients with type 2 diabetes mellitus are not influenced by the level of plasma glycaemia.
    Ezenwaka CE; Offiah NV
    West Indian Med J; 2001 Dec; 50(4):288-93. PubMed ID: 11993019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
    Vázquez LA; Rodríguez Á; Salvador J; Ascaso JF; Petto H; Reviriego J
    BMC Cardiovasc Disord; 2014 Nov; 14():153. PubMed ID: 25361574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effectiveness and safety of liraglutide in clinical practice.
    Ponzani P
    Minerva Endocrinol; 2013 Mar; 38(1):103-12. PubMed ID: 23435446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term intraindividual variability of serum lipids in patients with type I and type II diabetes.
    Tsalamandris C; Panagiotopoulos S; Allen TJ; Waldrip L; Van Gaal B; Goodall I; Jerums G
    J Diabetes Complications; 1998; 12(4):208-14. PubMed ID: 9647339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Persistent Efficacy of Diabetes Remission and Decline of Cardiovascular Risk After Laparoscopic Sleeve Gastrectomy: a Preliminary 1-Year Study.
    Huang YM; Wang W; Wei SC; Lee PF; Hsu YC; Tu WL; Chen HH
    Obes Surg; 2022 Oct; 32(10):3289-3297. PubMed ID: 35871264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.
    Erdman DM; Cook CB; Greenlund KJ; Giles WH; El-Kebbi I; Ryan GJ; Gallina DL; Ziemer DC; Dunbar VG; Phillips LS
    Diabetes Care; 2002 Jan; 25(1):9-15. PubMed ID: 11772894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
    Nichols GA; Joshua-Gotlib S; Parasuraman S
    J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.